Systems, methods, and apparatus for producing nitric oxide reference to related applications

The system integrates nitric oxide formation and delivery with centralized control, addressing the challenges of gas management in ECMO setups by providing precise control and monitoring, enhancing clinical efficiency and safety.

WO2026241229A1PCT designated stage Publication Date: 2026-11-19VERO BIOTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/027738
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-12
Filing Date
2026-05-12
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing nitric oxide delivery systems for patients with compromised lungs or undergoing ECMO treatment face challenges in coordinating the generation, control, and monitoring of multiple gases, requiring separate equipment and manual clinician intervention, lacking a centralized user interface for precise gas management.

Method used

A system comprising a first apparatus for forming nitric oxide, a second apparatus for delivering gases, and a control unit for centralized control and communication, allowing for integrated management of sweep and breathing gases in cardiopulmonary bypass setups.

Benefits of technology

Enables precise control and monitoring of gas concentrations in ECMO systems, improving patient safety and reducing the need for manual coordination, thereby enhancing clinical efficiency and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026027738_19112026_PF_FP_ABST
    Figure US2026027738_19112026_PF_FP_ABST
Patent Text Reader

Abstract

Disclosed herein is a system comprising: (a) a first apparatus configured to form an amount of nitric oxide, (b) a second apparatus configured to be releasably attached to (i) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / or (ii) a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; and (c) a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.
Need to check novelty before this filing date? Find Prior Art

Description

Attorney Docket No. 11637-054WO1SYSTEMS, METHODS, AND APPARATUS FOR PRODUCING NITRIC OXIDE REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the benefit of U.S. Provisional Application No.63 / 804,185 filed May 12, 2025, the content of which is incorporated herein by reference in their entirety.FIELD

[0002] Some aspects described herein relate to a medical device and, more particularly, to systems and methods for producing and delivering a gas that includes nitric oxide.BACKGROUND

[0003] Some aspects described herein relate to the production of nitric oxide (NO), which is then typically delivered to a patient in a medical setting.

[0004] Nitric oxide is a vasodilator indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation, particularly in term and near-term neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support. Low concentrations of inhaled nitric oxide can also prevent, reverse, or limit the progression of disorders, which can include, but are not limited to, acute pulmonary vasoconstriction, traumatic injury, aspiration or inhalation injury, fat embolism in the lung, acidosis, inflammation of the lung, adult respiratory distress syndrome, acute pulmonary edema, acute mountain sickness, post cardiac surgery acute pulmonary hypertension, persistent pulmonary hypertension of a newborn, perinatal aspiration syndrome, hyaline membrane disease, acute pulmonary thromboembolism, heparin-protamine reactions, sepsis, asthma and status asthmaticus or hypoxia. Nitric oxide can also be used to treat chronic pulmonary hypertension, bronchopulmonary dysplasia, chronic pulmonary thromboembolism, and idiopathic or primary pulmonary hypertension or chronic hypoxia.

[0005] Inhaled nitric oxide therapy typically involves the delivery of nitric oxide in parts per billion to parts per million concentrations within a breathing gas,Attorney Docket No. 11637-054WO1generally composed of air or oxygen-enriched air. This breathing gas may contain other components, such as anesthetic agents, nebulized liquids, or other gaseous components, and it is typically conveyed to a patient using either a mechanical or manual ventilation device. In some inhaled nitric oxide delivery systems, the nitric oxide is provided within pressurized tanks, whereas in other systems, the nitric oxide may be generated on demand within the delivery system itself. One such system is described in US 11,744,978, the content of which is incorporated herein in its entirety. In this approach, nitric oxide is produced by a chemical reaction between NO2 gas and an antioxidant, wherein the NO2 gas is produced through a phase-change of liquid N2O4. In such systems, the liquid IShO s typically housed in a pressure vessel with components required for reaction control (e.g., heating and cooling components), reactant mixing, and measurement co-located with the reactants themselves. Although this is an effective approach, there is a need for a system wherein the reactants required to create nitric oxide gas for a patient are housed within a simple one-time-use component, and the components that are required to initiate, contain, measure, and control the reaction reside in a location where they can be used many times. This creates the need for novel packaging, geometries, and orientations of reactants, as well as novel loading, activation, and ejection mechanisms.

[0006] While mechanical ventilation is the most common form of life support for people with compromised lungs, it can only provide gas flow into and out of the lungs for the exchange of oxygen and carbon dioxide with the blood.Extracorporeal Membrane Oxygenation (ECMO) treatment is a specialized type of cardiopulmonary bypass (CPB) and a form of life support that can also be utilized on patients whose lungs and hearts are compromised to exchange oxygen and carbon dioxide directly with the blood. ECMO pumps blood out of the body and sends it through a membrane oxygenator (artificial lung) that removes carbon dioxide and adds oxygen to the blood. This blood is then rewarmed and returned to the body, allowing the lungs and heart to rest and / or heal. Common conditions that ECMO treats include Acute Respiratory Distress Syndrome (ARDS), heart trauma, pulmonary embolism, infants and newborns born prematurely with lung and heart problems, and it is also used in surgeries and transplants, including recovery after surgery. During ECMO treatment, a patient often remains onAttorney Docket No. 11637-054WO1mechanical ventilation to keep the lungs mildly ventilated and open as well as to supplement ECMO blood flow rates. While the addition of nitric oxide gas to mechanical ventilation gas is common, it has also been found to be beneficial to add nitric oxide gas to the ECMO treatment circuit. The ECMO treatment circuit consists of a gas flow called “sweep” gas that is generally composed of air and oxygen but may also contain other gases or anesthetic agents. This gas is directed to a membrane oxygenator to remove carbon dioxide and transfer oxygen to the blood that is passed through the device. Adding nitric oxide to this sweep gas can be beneficial, as nitric oxide gas has anticoagulation properties, which can reduce or prevent the formation of clots in the membrane oxygenator, leading to extended life and reduced oxygenator changeouts. These benefits have a positive impact on both the cost of care as well as patient safety. An apparatus for controlling the delivery of nitric oxide to the ECMO sweep gas while simultaneously offering the capability to deliver nitric oxide to the patient ventilator circuit is described in US Patent Application No. 63 / 685,413, the content of which is incorporated herein in its entirety. Nitric oxide delivered to a patient ventilator is typically called inhaled nitric oxide or iNO, while nitric oxide delivered to sweep gas is typically called sweep NO or sNO. While this apparatus enables dual-dosing of nitric oxide to both the membrane oxygenator sweep gas as well as the patient ventilation circuit, there are additional challenges in ECMO that remain.

[0007] For example, the generation and control of the sweep gas itself and its component gases typically require the operation of multiple systems and monitors. A typical setup often includes a gas blender to create the oxygen-enriched air flow (the sweep gas), a nitric oxide delivery system such as that described above to add nitric oxide to this sweep gas, and additional equipment for adding and controlling other gases such as CO2. Independently monitoring this mixture while balancing the delivery and gas mixing using different pieces of equipment is challenging to control because each piece of equipment is not in communication with the others, and coordination falls on the clinician. Accordingly, there is a need for an apparatus that can precisely control and monitor all of the gases present in the sweep gas flow from one centralized user interface, where the clinician can set the flow and all gas concentration parameters. For example, the ability to deliver sweep gas that includes medical air, oxygen, nitric oxide, and carbon dioxide isAttorney Docket No. 11637-054WO1desired. Because the oxygenator exchanges both oxygen and carbon dioxide with the blood, the ability to add carbon dioxide into the sweep gas to independently control the exchange of that gas, in addition to oxygen, is beneficial.

[0008] This clinical need and all other needs are at least partially addressed by this disclosure.SUMMARY

[0009] The present disclosure is directed to a system comprising: (a) a first apparatus configured to form an amount of nitric oxide, (b) a second apparatus that is configured to be releasably attached to (i) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / or (ii) a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; and (c) a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0010] Also disclosed herein is a system comprising: a first apparatus configured to form an amount of nitric oxide, a second apparatus that is configured to be releasably attached to the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; wherein the second apparatus is configured to deliver a breathing gas to a patient; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0011] In still further aspects, the disclosure is directed to a method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing a system comprising: (a) a first apparatus configured to form an amount of nitric oxide, (b) a second apparatus that is configured to be releasably attached to (i) the first apparatus, such that a fluid and / or aAttorney Docket No. 11637-054WO1communication connectivity is formed between the second apparatus and the first apparatus; and / or (ii) a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; and c) a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0012] Still further disclosed herein is a method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing a first apparatus configured to form an amount of nitric oxide, releasably attaching the first apparatus to a second apparatus such that a fluid and / or communication connectivity is formed between the first apparatus and the second apparatus; releasably attaching the second apparatus to the CPB setup; wherein the second apparatus is configured to deliver the sweep gas to the CPB setup; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both when the first apparatus and the second apparatus are communicatively connected.

[0013] Additional advantages will be set forth in part in the description that follows, and in part will be obvious from the description or can be learned by practice of the aspects described below. The advantages described below will be realized and attained by means of the chemical compositions, methods, and combinations thereof, particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.BRIEF DESCRIPTION OF THE DRAWINGS

[0014] FIGURE 1 is a schematic of an exemplary system according to one aspect of the disclosure.Attorney Docket No. 11637-054WO1

[0015] FIGURE 2 is a schematic of an exemplary system according to one aspect of the disclosure.

[0016] FIGURE 3 is a schematic of an exemplary system according to one aspect of the disclosure.

[0017] FIGURE 4 is a schematic of an exemplary system according to one aspect of the disclosure.

[0018] FIGURE 5 is a schematic of an exemplary system according to one aspect of the disclosure.

[0019] FIGURE 6 is a schematic of an exemplary graphical user interface according to one aspect of the disclosure.

[0020] FIGURE 7 shows a schematic of an exemplary system according to one aspect of the disclosure.

[0021] FIGURE 8 is a schematic of an exemplary system according to one aspect of the disclosure.

[0022] The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects described below.DETAILED DESCRIPTION

[0023] The present invention can be understood more readily by reference to the following detailed description, examples, drawings, and claims, and their previous and following description. However, before the present articles, systems, and / or methods are disclosed and described, it is to be understood that this invention is not limited to the specific or exemplary aspects of articles, systems, and / or methods disclosed unless otherwise specified, as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting.

[0024] The following description of the invention is provided as an enabling teaching of the invention in its best, currently known aspect. To this end, those skilled in the relevant art will recognize and appreciate that many changes can be made to the various aspects of the invention described herein while still obtaining the beneficial results of the present invention. It will also be apparent that some ofAttorney Docket No. 11637-054WO1the desired benefits of the present invention can be obtained by selecting some of the features of the present invention without utilizing other features. Accordingly, those of ordinary skill in the pertinent art will recognize that many modifications and adaptations to the present invention are possible and may even be desirable in certain circumstances and are a part of the present invention. Thus, the following description is again provided as illustrative of the principles of the present invention and not in limitation thereof.DEFINITIONS

[0025] As used herein, the terms "optional" or "optionally" mean that the subsequently described event or circumstance can or cannot occur and that the description includes instances where said event or circumstance occurs and instances where it does not.

[0026] It is appreciated that certain features of the disclosure, which are, for clarity, described in the context of separate aspects, can also be provided in combination in a single aspect. Conversely, various features of the disclosure, which are, for brevity, described in the context of a single aspect, can also be provided separately or in any suitable subcombination.

[0027] As used in the description and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, a reference to "a single-use unit" includes not only one but also two or more such units, and a reference to "an apparatus" includes not only one but also two or more such apparatuses and the like.

[0028] Throughout the description and claims of this specification, the word "comprise" and other forms of the word, such as "comprising" and "comprises," are open, non-limiting terms and mean "including but not limited to," and are not intended to exclude, for example, other additives, segments, integers, or steps. Furthermore, it is to be understood that the terms "comprise," "comprising," and "comprises" as they relate to various aspects, elements, and features of the disclosed invention also include the more limited aspects of "consisting essentially of" and "consisting of."Attorney Docket No. 11637-054WO1

[0029] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In this specification and in the claims which follow, reference will be made to a number of terms that shall be defined herein.

[0030] For the terms "for example" and "such as" and grammatical equivalences thereof, the phrase "and without limitation" is understood to follow unless explicitly stated otherwise. It is further understood that these phrases are used for explanatory purposes only. It is further understood that the term "exemplary," as used herein, means "an example of' and is not intended to convey an indication of a preferred or ideal aspect.

[0031] The expressions "ambient temperature" and "room temperature" as used herein are understood in the art and refer generally to a temperature from 20 °C to 35 °C.

[0032] All disclosed values also include values that fall within ±10% variation from the disclosed value unless otherwise indicated or inferred. In other words, if a range of 1 to 10 is disclosed, then a range of about 1 to about 10 is disclosed. In such aspects, it is understood that the amount or value in question can be the exact value or a value that provides equivalent results or effects as recited in the claims or taught herein. That is, amounts, sizes, formulations, parameters, and other quantities and characteristics include both exact values but also approximate, larger or smaller values as desired, reflecting tolerances, conversion factors, rounding, measurement error, and the like, and other factors known to those of skill in the art such that equivalent results or effects are obtained. In some circumstances, the value that provides equivalent results or effects cannot be reasonably determined. In general, an amount, size, formulation, parameter, or other quantity or characteristic is "about," "approximate," or "at or about," whether or not expressly stated to be such. Where "about," "approximate," or "at or about" is used before a quantitative value, the parameter also includes the specific quantitative value itself unless expressly stated otherwise.

[0033] As used herein, the term or phrase “effective,” “effective amount,” or “conditions effective to” refers to such amount or condition that is capable of performing the function or property for which an effective amount or condition isAttorney Docket No. 11637-054WO1expressed. As will be pointed out below, the exact amount or particular condition required will vary from one aspect to another, depending on recognized variables such as the materials employed and the processing conditions observed. Thus, it is not always possible to specify an exact “effective amount” or “condition effective to.” However, it should be understood that an appropriate, effective amount will be readily determined by one of ordinary skill in the art.

[0034] When a range is expressed, a further aspect includes from the one particular value and the other particular value. For example, where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure, e.g., the phrase "x to y" includes the range from 'x' to 'y' as well as the range greater than 'x' and less than 'y'. The range can also be expressed as an upper limit, e.g., 'x, y, z, or less' and should be interpreted to include the specific ranges of ‘x,’ ‘y,’ ‘z,’ 'about x, ' 'about y, ' and 'about z' as well as the ranges of 'less than x, ' 'less than y, or 'less than z, ' or 'less than about x, ' 'less than about y, and 'less than about z.' Likewise, the phrase ' x, y, z, or greater' should be interpreted to include the specific ranges of ‘x,’ ‘y,’ ‘z,’ 'about x,' 'about y, ' and 'about z' as well as the ranges of 'greater than x, ' greater than y, ' 'greater than z,' or 'greater than about x, ' greater than about y, ' 'greater than about z.' In addition, the phrase " 'x' to 'y'," where 'x' and 'y' are numerical values, also includes "about 'x' to about 'y'."

[0035] Such a range format is used for convenience and brevity and, thus, should be interpreted flexibly to include not only the numerical values explicitly recited as the limits of the range but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. To illustrate, a numerical range of " 0.1% to 5%" should be interpreted to include not only the explicitly recited values of 0.1% to 5% but also include individual values (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.5% to 1.1%; 5% to 2.4%; 0.5% to 3.2%, and 0.5% to 4.4%, and other possible sub-ranges) within the indicated range.

[0036] Throughout this disclosure, various aspects of the invention can be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as anAttorney Docket No. 11637-054WO1inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, a description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as individual numbers within that range, for example, 1 , 2, 2.7, 3, 4, 5, 5.3, 6 and any whole and partial increments therebetween. This applies regardless of the breadth of the range.

[0037] In still further aspects, when the specific values are disclosed between two end values, it is understood that these end values can also be included.

[0038] In still further aspects, when the range is given, and exemplary values are provided, it is understood that any ranges can be formed between any exemplary values within the broadest range. For example, if individual numbers 1 , 2, 3, 4, 5, 6, 7, etc. are disclosed, then the ranges 1-7, 2-7, 3-7, 4-7, 5-7, 6-7, 1-6, 1-5, 1-4, 1-3, 1-2, 2-6, 2-5, etc. are also disclosed.

[0039] References in the specification and concluding claims to parts by weight of a particular element or component in a composition denote the weight relationship between the element or component and any other elements or components in the composition or article for which a part by weight is expressed. Thus, in a mixture containing 2 parts by weight of component X and 5 parts by weight, components Y, X, and Y are present at a weight ratio of 2:5 and are present in such a ratio regardless of whether additional components are contained in the mixture.

[0040] A weight percent (wt.%) of a component, unless specifically stated to the contrary, is based on the total weight of the formulation or composition in which the component is included.

[0041] It will be understood that when an element is referred to as being "connected" or "coupled" to another element, it can be directly connected or coupled to the other element, or intervening elements may be present. In contrast, when an element is referred to as being "directly connected" or "directly coupled" to another element, there are no intervening elements present. Other words usedAttorney Docket No. 11637-054WO1to describe the relationship between elements or layers should be interpreted in a like fashion (e.g., "between" versus "directly between," "adjacent" versus "directly adjacent," "on" versus "directly on").

[0042] As used herein, the term "and / or" includes any and all combinations of one or more of the associated listed items.

[0043] It will be understood that although the terms "first," "second," etc., may be used herein to describe various elements, components, regions, layers, and / or sections. These elements, components, regions, layers, and / or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer, or section from another element, component, region, layer, or section. Thus, a first element, component, region, layer, or section discussed below could be termed a second element, component, region, layer, or section without departing from the teachings of example aspects.

[0044] As used herein, the term "substantially" means that the subsequently described event or circumstance completely occurs or that the subsequently described event or circumstance generally, typically, or approximately occurs.

[0045] Still further, the term "substantially" can, in some aspects, refer to at least 90 %, at least 95 %, at least 99 %, or 100 % of the stated property, component, composition, or other condition for which substantially is used to characterize or otherwise quantify an amount.

[0046] In other aspects, as used herein, the term "substantially free," when used in the context of a composition or component of a composition that is substantially absent, is intended to refer to an amount that is then 1 % by weight, e.g., less than 0.5 % by weight, less than 0.1 % by weight, less than 0.05 % by weight, or less than 0.01 % by weight of the stated material, based on the total weight of the composition.

[0047] Spatially relative terms, such as "beneath," "below," "lower," "above," "upper," "bottom," "top," and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, inAttorney Docket No. 11637-054WO1addition to the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as "below" or "beneath" other elements or features would then be oriented "above" the other elements or features. Thus, the term "below" can encompass both an orientation of above and below. The device may be otherwise oriented (rotated 90 degrees or at other orientations), and the spatially relative descriptors used herein are interpreted accordingly.

[0048] Terms such as "proximal," "distal," "radially outward," "radially inward," "outer," "inner," and "side" describe the orientation and / or location of portions of the components or elements within a consistent but arbitrary frame of reference which is made clear by reference to the text and the associated drawings describing the components or elements under discussion. Such terminology can include the words specifically mentioned above, derivatives thereof, and words of similar import.

[0049] As used herein, "treating" and "treatment" generally refer to obtaining a desired pharmacological or physiological effect. The effect can be, but does not necessarily have to be, prophylactic in preventing or partially preventing a disease, symptom, or condition. The effect can be therapeutic regarding a partial or complete cure of a disease, condition, symptom, or adverse effect attributed to the disease, disorder, or condition. The term "treatment" as used herein can include any treatment of a disorder in a subject, particularly a human. It can include any one or more of the following: (a) preventing the disease from occurring in a subject who may be predisposed to the disease but has not yet been diagnosed as having it; (b) inhibiting the disease, i.e. , arresting its development; and (c) relieving the disease, i.e., mitigating or ameliorating the disease or its symptoms or conditions. The term "treatment," as used herein, can refer to both therapeutic treatment alone, prophylactic treatment alone, or both therapeutic and prophylactic treatment. Those in need of treatment (i.e., subjects in need thereof) can include those already with the disorder or those in which the disorder is to be prevented. As used herein, the term "treating" can include inhibiting the disease, disorder, or condition, e.g., impeding its progress, and relieving the disease, disorder, or condition, e.g., causing regression of the disease, disorder, or condition. Treating the disease, disorder, or condition can include ameliorating at least one symptomAttorney Docket No. 11637-054WO1of the particular disease, disorder, or condition, even if the underlying pathophysiology is not affected, e.g., such as treating the pain of a subject by administration of an analgesic agent even though such agent does not treat the cause of the pain.

[0050] It is further understood that the term “mixing means” as described herein refers to any components, elements, or processes that allow mixing of the gases in the disclosed herein apparatuses. In certain aspects, the mixing means can include one or more mixing chambers disposed within the apparatus, one or more manifolds disposed within the apparatus configured to receive the gases and mix them in predetermined compositions and amounts, one or more valves, one or more flow controllers, any combination thereof. It is further understood that these mixing means are disposed within the disclosed apparatuses] as described in detail below.

[0051] It is understood that the term "mammal" refers to any mammal that requires a therapeutic amount of nitric oxide for whatever reason. In certain exemplary and unlimiting aspects, the mammal is a human patient. However, it is understood that the formed nitric oxide can be delivered to any other known mammal if needed.

[0052] As used herein, the term "sweep gas" refers to a gas flow generally composed of air and oxygen, which may also contain other gases, such as nitric oxide, therapeutical agents, or anesthetic agents. This gas is directed to a membrane oxygenator to remove carbon dioxide and transfer oxygen to the blood that is passed through the device.

[0053] As used herein, the term "breathing gas" refers to a gas composition delivered to a patient for respiration. The breathing gas is generally composed of air or oxygen-enriched air. This breathing gas may contain other components, such as anesthetic agents, nebulized liquids, or other gaseous components, such as nitric oxide, for example.

[0054] As used herein, the term "mixed gas" refers to a gas composition formed by combining two or more gases in a mixing means. In some aspects, the mixed gas may comprise oxygen, air, carbon dioxide, or a combination thereof. TheAttorney Docket No. 11637-054WO1mixed gas may become a sweep gas or breathing gas upon the addition of nitric oxide or may itself constitute the sweep gas or breathing gas.

[0055] As used herein, the term "therapeutic amount" refers to an amount of a substance, such as nitric oxide, that is capable of achieving a desired pharmacological or physiological effect in a subject. The therapeutic dose may be defined by a healthcare professional based on the specific condition being treated and the patient's needs.

[0056] As used herein, the terms "fluid communication" or "fluidic connection" refer to a configuration in which two or more components are connected such that a fluid, including a gas or liquid, can flow between them. Fluid communication may be direct or include intervening components such as conduits, valves, or flow controllers.

[0057] As used herein, the terms "communication connectivity" or "communicatively connected" refer to a configuration in which two or more components are connected such that data, signals, or commands can be transmitted between them. The communication connective also includes electrical connections between components of the system. The communication connectivity may be wired, wireless, or a combination thereof.

[0058] As used herein, the term "releasably attached" refers to a connection between two components that can be established and subsequently disconnected without damaging either component. The releasable attachment may include mechanical, electrical, and / or fluidic connections.

[0059] As used herein, the term "standalone device" refers to an apparatus that can operate independently when another apparatus is not attached to it.

[0060] As used herein, the term "dosing port" refers to an outlet or connection point through which a controlled amount of a gas, such as nitric oxide, is delivered or injected into another gas stream or system.

[0061] As used herein, the term "receptacle" refers to a housing, compartment, or receiving structure configured to hold or host a component, such as a source of nitric oxide.Attorney Docket No. 11637-054WO1

[0062] As used herein, the term "oxygen-enriched air" refers to air having an oxygen concentration greater than that of ambient atmospheric air (approximately 21% oxygen by volume).

[0063] As used herein, the term "predetermined portion" refers to a quantity or fraction that is established, set, or determined in advance, such as by a control unit, a healthcare professional, or system parameters.

[0064] As used herein, the term "membrane oxygenator" refers to a medical device that functions as an artificial lung, configured to remove carbon dioxide from blood and add oxygen to the blood. The membrane oxygenator may be used in cardiopulmonary bypass setups, including extracorporeal membrane oxygenation (ECMO) devices.

[0065] As used herein, the term "cassette" refers to a replaceable or insertable unit configured to be received by an apparatus for the purpose of forming or delivering nitric oxide. The cassette may contain reactants, such as a nitric oxide source, and may be configured for single- or limited-use applications.

[0066] As used herein, the term "nitric oxide dosing index" refers to a calculated value representing the total amount of nitric oxide being delivered to a patient. In some cases, the nitric oxide dosing index may be determined from delivery concentrations and delivery flow rates from one or more delivery circuits.

[0067] As used herein, the term "mode" refers to a configuration or operational state of an apparatus or system. For example, a "sweep gas mode" may refer to a configuration in which the system is set to deliver a sweep gas to a cardiopulmonary bypass setup, while a "breathing gas mode" may refer to a configuration in which the system is set to deliver a breathing gas to a patient.

[0068] As used herein, the term "docking connection" refers to an interface configured to establish an electrical, mechanical, and / or fluidic connection between two apparatuses. The docking connection may be configured to be concealed or protected when not in use.

[0069] As used herein, the term "source of nitric oxide" refers to any component, material, or device capable of providing or generating nitric oxide. The source of nitric oxide may include, without limitation, pressurized tanks containingAttorney Docket No. 11637-054WO1nitric oxide, cassettes configured to form nitric oxide in situ, or single-use containers comprising reactants for nitric oxide generation.

[0070] As used herein, the term "single-use container" refers to a container designed for single use and then discarded or recycled. In some aspects, the single-use container may comprise reactants for forming nitric oxide, such as liquid N2O4 and an antioxidant material.

[0071] As used herein, the term "antioxidant" refers to a substance capable of reacting with nitrogen dioxide (NO2) or dinitrogen tetroxide (N2O4) to produce nitric oxide.

[0072] As used herein, the term "control unit" refers to a component or assembly configured to manage, direct, or regulate the operation of one or more apparatuses. The control unit may include processors, memory, user interfaces, and associated circuitry for receiving inputs, processing data, and providing outputs or directives.

[0073] As used herein, the term "graphical user interface" or "GUI" refers to a visual display configured to present information to a user and, in some aspects, to receive user inputs. The GUI may display operational parameters, status information, alerts, and other data reflecting the operation of the system.

[0074] Some aspects described herein relate to methods. It should be understood that such methods can be computer-implemented. That is, where the method or other events are described herein, it should be understood that they may be performed by a computing device having a processor and a memory. Memory of a computing device is also referred to as a non-transitory computer-readable medium, which can include instructions or computer code for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also referred to as code) may be those designed and constructed for a specific purpose or purpose. Examples of non-transitory computer-readable media include, but are not limited to magnetic storage mediaAttorney Docket No. 11637-054WO1such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc / Digital Video Discs (CD / DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules, Read-Only Memory (ROM), Random-Access Memory (RAM) and / or the like. One or more processors can be communicatively coupled to the memory and operable to execute the code stored on the non-transitory processor-readable medium. Examples of processors include general purpose processors (e.g., CPUs), Graphical Processing Units, Field Programmable Gate Arrays (FPGAs), Application Specific Integrated Circuits (ASICs), Digital Signal Processor (DSPs), Programmable Logic Devices (PLDs), and the like. Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as those produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, aspects may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.), or other suitable programming languages and / or development tools.Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.

[0075] While aspects of the present invention can be described and claimed in a particular statutory class, such as the system statutory class, this is for convenience only, and one of ordinary skill in the art will understand that each aspect of the present invention can be described and claimed in any statutory class. Unless otherwise expressly stated, it is in no way intended that any method or aspect set forth herein be construed as requiring that its steps be performed in a specific order. Accordingly, where a method claim does not specifically state in the claims or descriptions that the steps are to be limited to a specific order, it is in no way intended that an order be inferred in any respect. This holds for any possible non-express basis for interpretation, including matters of logic with respect to the arrangement of steps or operational flow, plain meaning derived from grammaticalAttorney Docket No. 11637-054WO1organization or punctuation, or the number or type of aspects described in the specification.

[0076] The present invention may be understood more readily by reference to the following detailed description of various aspects of the invention and the examples included therein, and to the Figures and their previous and following description.SYSTEM

[0077] Disclosed herein is a system comprising at least two apparatuses that are fluidically and / or communicatively connected to each other. In certain aspects, disclosed herein is a first apparatus configured to form an amount of nitric oxide and a second apparatus that is configured to be releasably attached to the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus. In still further aspects, the second apparatus can be in addition to or in alternative to be releasably attached to a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup. In yet still further aspects, the second apparatus is configured to deliver a sweep gas to the CPB setup. In yet still further aspects, the system comprises a control unit that is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0078] In still further aspects, the control unit can be positioned anywhere in the system. In certain exemplary and unlimiting aspects, the control unit is positioned within the first apparatus.

[0079] The exemplary schematic of the disclosed herein system is shown in FIG. 1. In this figure, the first apparatus 200 is shown in fluidic and communicative connection with the second apparatus 300. The second apparatus 300 is in further fluidic and communicative connection with the CPB setup 400. The first apparatus is configured to form nitric oxide. The receptacles 202 that host a source that forms the nitric oxide are also positioned within the first apparatus. The control unitAttorney Docket No. 11637-054WO1comprises a graphical user interface (GUI) 204, which is hosted within the first apparatus.

[0080] In still further aspects, the sweep gas delivered by the second apparatus to the CPB setup comprises a predetermined portion of the amount of nitric oxide that is formed by the first apparatus. In still further aspects, the sweep gas comprises an oxygen-enriched air.

[0081] In certain aspects, the first apparatus can operate as a standalone device when the second apparatus is not attached to the first apparatus and is configured to directly deliver the amount of nitric oxide to a patient. The exemplary standalone first apparatus is shown in FIG. 8 and is described in more detail below. When the first apparatus operates as a standalone apparatus, the amount of nitric oxide formed by the first apparatus can be delivered to the patient by any known means in the art. For example, and without limitations, the amount of nitric oxide can be delivered directly to a breathing line that arrives at the patient. Yet in other aspects, the amount of nitric oxide can be delivered to the patient through a ventilation device. Yet in still other aspects, the amount of nitric oxide can be delivered directly to the patient and through a ventilation device.

[0082] It is understood that the amount of nitric oxide can be any amount that the first apparatus can generate and that is suitable for the desired application. In certain aspects, the amount of nitric oxide is a therapeutic amount that is defined by a healthcare professional. Yet in other aspects, the amount of nitric oxide formed by the first apparatus can be different from the therapeutic amount. In such aspects, for example, a portion of the amount of nitric oxide that is either directly delivered to the patient or is present in the sweep gas is a therapeutic portion that is defined by a health care professional.

[0083] In still further aspects, and as shown in FIG. 4, the second apparatus 300 can comprise one or more gas inlets 303 and a mixing means (not shown) positioned within the second apparatus. Again, as disclosed above, it is understood that the mixing means can refer to any element, component, or process that allows mixing of the incoming gases in the desired composition. In certain aspects, the mixing means can comprise and include one or more mixing chambers, one or more manifolds, one or more valves, one or more flowAttorney Docket No. 11637-054WO1controllers, any combination thereof, and so on. In such exemplary and unlimiting aspects, the one or more gas inlets 303 are in fluid communication with the mixing means (that is, within the body of the second apparatus), wherein each of the one or more gas inlets is configured independently to deliver one or more gases to the mixing means. For example, and without limitations, the one or more gas inlets can comprise an oxygen inlet (303a), an air inlet (303b), a carbon dioxide inlet (303c), or a combination thereof. It is understood that FIG. 4 is only exemplary, and the positioning of the inlets can be in any sequence. In some aspects, only one gas inlet can be present. While in other aspects, two gas inlets can be present. While in still further aspects, three gas inlets can be present. While in still further aspects, more than three gas inlets can be present.

[0084] In certain exemplary and unlimiting aspects, one or more gas inlets can comprise, in addition to the inlets mentioned above or in the alternative, a hydrogen inlet, a helium inlet, ora combination thereof.

[0085] In certain aspects, the one or more gas inlets are configured to deliver an amount of the one or more gases simultaneously to the mixing means to form a mixed gas. In other exemplary aspects, the one or more gas inlets are configured to deliver an amount of the one or more gases in a predetermined sequence to the mixing means to form a mixed gas.

[0086] It is further understood that the amount and the delivery sequence of the one or more gases are at least partially controlled by the control unit 204. It is further understood that the aspects where additional control units are present are also disclosed. For example, and without limitations, a further control unit can be present within the second apparatus. This further control unit can work in alliance with the control unit 204 that is positioned within the first apparatus. This further control unit can have various control functions, depending on the desired applications. For example, this further control unit can switch the second apparatus on / off, provide some additional alert functionalities (for example, leaks, malfunctions, gas connections interruptions, or processing steps, data transfer interruptions, or processing steps), or any other functionality that can assist the user in the system operation. This further control unit 304 can be positioned on the back of the second apparatus, as shown in FIG. 4, or the front, as shown in FIG. 7.Attorney Docket No. 11637-054WO1

[0087] In still further aspects, the second apparatus 200 can comprise a gas outlet 305 that is in fluid communication with the mixing means and is configured to deliver a mixed gas 301 to the CPB setup 400. In certain aspects, if desired, the second apparatus can comprise more than one gas outlet.

[0088] In certain aspects, the predetermined portion of the amount of nitric oxide is injected from a dosing port 201 in the first apparatus into the mixed gas 301 after it leaves the second apparatus, thereby forming the sweep gas comprising the predetermined portion of the amount of nitric oxide 307 that is delivered to the CPB setup.

[0089] In still further aspects (not shown in the figures), the predetermined portion of the amount of nitric oxide is delivered into the mixing means in a predetermined delivery sequence, and wherein the mixed gas 301 is the sweep gas 301 that is delivered to the CPB setup. In such aspects, the nitric oxide gas formed in the first apparatus can be delivered to the mixing means of the second apparatus by any fluidic means. For example, and without limitations, the second apparatus can have a separate inlet configured to receive the predetermined amount of the formed nitric oxide. Again, as understood, the sequence of delivering this predetermined amount of nitric oxide can be selected based on the desired application. For example, it can be delivered simultaneously with all other gases, or before and / or after delivering any of the other gases, as long as the desired mixture is formed and safety concerns are addressed.

[0090] In still further aspects, the second apparatus can comprise an inlet to deliver an amount of water or water vapor to a mixed gas. In certain aspects, the second apparatus can, in addition to or in the alternative, comprise a humidification mechanism configured to add water vapor to a mixed gas.

[0091] In certain aspects, in addition to the aspects disclosed above or in alternative, the first apparatus and / or second apparatus can be in fluid communication with a humidifying apparatus configured to control the humidity of the sweep gas. In such exemplary and unlimiting aspects, the humidifying apparatus can be positioned within the first apparatus and / or the second apparatus.Attorney Docket No. 11637-054WO1

[0092] In some aspects, the first apparatus comprises one or more fluid controlling components, wherein the one or more fluid controlling components comprise valves, flow controllers, sensors, or any combination thereof. In certain aspects, the second apparatus comprises one or more fluid controlling components, wherein the one or more fluid controlling components comprise valves, flow controllers, sensors, or any combination thereof. In still further aspects, the one or more fluid controlling components (present either in the first apparatus or the second apparatus) are controlled by the control unit 204. In some aspects, the one or more fluid controlling components that are present in the second apparatus can additionally be at least partially controlled by the further control unit.

[0093] In still further aspects, the one or more fluid controlling components present in the second apparatus are configured to form a mixed gas having a predetermined composition.

[0094] In still further aspects, the CPB setup can be any setup that allows for providing a breathing gas to the patient while bypassing the cardiopulmonary system of the patient. In certain exemplary and unlimited aspects, the CPB setup 400 can comprise an extracorporeal membrane oxygenation (ECMO) device. As discussed above, ECMO pumps blood 401 out of the body and sends it through a membrane oxygenator (artificial lung) that removes carbon dioxide and adds oxygen to the blood. This blood is then rewarmed and returned 403 to the body, allowing the lungs and heart to rest and / or heal.

[0095] The sweep gas comprising nitric oxide 307 is directed to a membrane oxygenator to remove carbon dioxide and transfer oxygen to the blood that is passed through the device. As discussed above, the presence of nitric oxide to the sweep gas can be beneficial as nitric oxide gas has anticoagulation properties which can reduce or prevent the formation of clots in the membrane oxygenator, leading to extended life and reduced oxygenator changeouts. In certain aspects, the sweep gas can also comprise anesthetic agents if needed.

[0096] In the setup of the ECMO circuit, the patient’s blood 401 (FIG. 1) is pumped from the body through an ECMO device (oxygenator) (CPB setup 400 is ECMO in this example) that adds oxygen to the blood and removes carbon dioxideAttorney Docket No. 11637-054WO1before being pumped back into the body (with blood rewarmed) 403. The oxygenation and carbon dioxide removal is effected by the flow of a sweep gas 307 provided by the second apparatus 300 which flows to the ECMO oxygenator 400. The control unit 204 allows the user to control the gas mixture composition, as well as the flow rate of each gas in the sweep gas 307. In some aspects, the system further includes a ventilator (not shown) that provides breathing gas to the patient’s lungs through mechanical breaths.

[0097] In certain aspects, the first apparatus can be flu idical ly connected to a ventilator that can be independent in fluid communication with the patient. If needed, the first apparatus can independently deliver a predetermined portion of the nitric oxide both to the sweep gas 307 to ECMO and to a ventilator and to the patient.

[0098] In further aspects, when the second apparatus 300 is attached to the first apparatus 200, concentrations of gas components present in the sweep gas 307, a flow rate, or a combination thereof, are controlled by the control unit 204. Again, as mentioned above, the control unit 204 comprises a graphical user interface (GUI) configured to display user information reflecting the operation of the system.

[0099] It is further understood that the displayed user information is different when the first apparatus and the second apparatus are attached and in electrical communication from the displayed user information when the first apparatus and the second apparatus are not attached. This way, the user can determine the correct compositions of the gases and their flow rates.

[0100] It is further understood that in certain aspects disclosed herein, the second apparatus is not independently operational when it is not attached to the first apparatus.

[0101] In still further aspects, when the first apparatus determines that the second apparatus is communicatively connected, the first apparatus activates a sweep gas mode to enable the second apparatus to deliver the sweep gas to the CPB setup. An exemplary reading of GUI in this aspect is shown in FIG. 6. In these exemplary aspects, the GUI shows set values for oxygen, carbon dioxide, theAttorney Docket No. 11637-054WO1predetermined portion of NO (sNO) present in the sweep gas, and the sweep gas flow rate (SGFR) with simultaneously dosing of nitric oxide to the patient ventilator (iNO).

[0102] The flow rate of the sweep gas 307 can be measured using a flow sensor (not shown). In addition, the sweep gas 307 can be sampled 206 using gas sampling ports (not shown) to determine the nitric oxide content, and optionally the content of other gases such as oxygen and nitrogen dioxide (FIG. 1). In other words, the first apparatus can sample the sweep gas to measure concentrations of gas components present in the sweep gas.

[0103] In certain aspects, due to the injection of nitric oxide 201 into the mixed gas 301 , there is some dilution of the oxygen in the sweep gas 307, and by measuring this, the apparatus can display the actual oxygen content of the diluted gas being supplied to the ECMO device on the graphical user interface (GUI) 204. Furthermore, the apparatus can control the injection of nitric oxide to achieve a target O2 dilution.

[0104] In certain aspects, the control unit analyses the concentrations of the gas components present in the sweep gas and, if needed, provides a directive to the first apparatus and / or second apparatus: a) to adjust gas concentration in the mixing means of the second apparatus, and / or b) to change the predetermined amount of nitric oxide.

[0105] In still further aspects, wherein the first apparatus comprises at least one air inlet; a first receptacle 202 configured to host a first source of nitric oxide 205; and a second receptacle 202 configured to host a second source of nitric oxide 205 (the exemplary source of nitric oxide is shown in FIG. 8).

[0106] In still further aspects, the control unit can independently determine whether the first apparatus is attached or not attached to the second apparatus and is configured to communicate with the first receptacle and the second receptacle and to selectively couple the at least one air inlet to the first receptacle and the second receptacle to deliver the amount of nitric oxide from the first source and / or the second source.Attorney Docket No. 11637-054WO1

[0107] In still further aspects, the first apparatus further comprises a first outlet coupled to the first receptacle and a second outlet coupled to the second receptacle (not shown). In aspects, when the first apparatus is not attached to the second apparatus, the first and the second outlets are configured to deliver the amount of nitric oxide to a subject. As discussed in detail above, this amount of nitric oxide can be delivered to the subject directly through the breathing line or through a ventilator.

[0108] In aspects when the first apparatus is attached to the second apparatus, the first and the second outlets are configured to deliver a predetermined portion of the amount of nitric oxide to the sweep gas.

[0109] In further aspects, the first and / or second source of nitric oxide can be connected to the dosing ports, flow sensor ports, and the like (not shown).

[0110] In still further aspects, the GUI unit 204 is able to check and communicate with each dosing system that are in communication with each receptacle. The user can independently set nitric oxide dosing concentrations for the sweep gas 307. If the first apparatus is also connected with a ventilator, the user can also set nitric oxide dosing concentration for inspiratory (breathing) gas flowing through the ventilator and the system can display both of these values on the GUI 204.

[0111] Furthermore, in some aspects, the system can provide a nitric oxide dosing index or value that represents the total amount of nitric oxide (the total nitric oxide dose) being delivered to the patient through both the ECMO circuit and the ventilator circuit. This nitric oxide dosing index or value can be presented as a single number which combines delivery concentrations and delivery flow rates and enables the user to quantify and view total nitric oxide delivery to the patient. For example, the nitric oxide dosing index or value can be determined using the following formula: ((Sweep gas flow rate x sweep gas nitric oxide concentration) + (ventilation gas flow rate times ventilation gas nitric oxide concentration)). This value can then be further scaled or non-dimensionalized for simplified presentation to a clinician / user as a nitric oxide dosing index.Attorney Docket No. 11637-054WO1

[0112] In some aspects, a user may target a total dose of nitric oxide to the patient which can be automatically partitioned by the system between the sweep gas and the inspiratory gas and can furthermore be controlled based on target limits for each delivery circuit (i.e. , the ECMO circuit and the ventilator circuit). The system through the use of software can determine an optimal split of nitric oxide delivery between the sweep gas and the inspiratory gas and suggest this to the user for confirmation or the system can alternatively automatically control these values based on provided inputs from the user. In some aspects, the system can include an electronic component that can communicate with a user through an external connection to a mobile device such as a smart phone. The system software can work with the electronic component to communicate with the mobile device through Bluetooth, Wi-Fi, or a cellular communication so that the user can view the performance of the system without seeing the system console GUI 204.

[0113] In some aspects, the system can accept inputs from patient monitoring, such as pulse oximetry (blood oxygen saturation), blood gas measurements (e.g., blood carbon dioxide saturation), and vital signs (e.g., pulse rate, temperature, respiration rate, blood pressure, and pH), which are used to assess the health of an ECMO patient. In this case, the system software can attempt to optimize, maximize, or minimize any of these patient parameters through the adjustment of nitric oxide dosing, including both the dosing levels as well as the split of delivery of nitric oxide between the sweep gas and the inspiratory gas, if present. This feedback loop would run separately from and provide inputs to the nitric oxide dose control feedback loops on each circuit (i.e., sweep gas and the inspiratory gas ).

[0114] In still further aspects, the amount of nitric oxide and / or the portion of the amount of nitric oxide can be adjusted based on the input from the ECMO device. In such exemplary and unlimiting aspects, the ECMO device input can include the status or detection of clotting or coagulation. In some aspects, the system may accommodate a very large sweep gas flow for the ECMO circuit or a very large inspiratory gas flow for the ventilator circuit by utilizing both cassettes to dose nitric oxide into the same circuit. Because both dosing systems (cassettes) are controlled within the same apparatus and can communicate with each other, high parts per million dosing of nitric oxide (e.g., 80 ppm) into high flows in liters perAttorney Docket No. 11637-054WO1minute (e.g., 70 liters per minute) can be provided to either the ECMO circuit or the ventilator circuit using a single system.

[0115] In some aspects, the system can be operated using an ECMO-specific mode or a CPB-specific mode (utilizing the ventilator). In this case, the system would be capable of nitric oxide dosing into many other setups and scenarios, but the activation of the “ECMO Mode” or “CPB Mode” would specifically set the software and hardware configurations to the operations described. A user can activate the modes by pressing a button on the console or the GUI, or the apparatus can activate the mode by recognizing the insertion of an “ECMO” or “CPB” cassette. The system can also read a barcode or RFID tag on the cassette or by other means of reading cassette data. Thus, the apparatus may either be completely directed to ECMO or ventilator usage, or it may have a mode that is ECMO-specific or CPB-specific (ventilator-specific).

[0116] It is understood that the nitric oxide source can be any source known in the art. In certain aspects, the nitric oxide source can be a tank of nitric oxide. In yet other aspects, the nitric oxide source can be a cassette configured to form nitric oxide in situ. One such system is described in US 11 ,744,978, the content of which is incorporated herein in its entirety.

[0117] In yet still further aspects, the nitric oxide source can be a single-use container. Such exemplary and unlimiting single use-container is disclosed in PCT application No. PCT / US25 / 25913, the content of which is enclosed herein in its entirety. In such exemplary and unlimiting aspects, the single-use container can be used for medical purposes and, more specifically, for forming a desired amount of nitric oxide that can then be delivered to the subject. In aspects disclosed herein, the single-unit use container is utilized upon request and, by the end of the use, can be discarded and / or recycled if needed.

[0118] In such aspects, the single-use container can comprise a liquid N2O4 or the liquid N2O4 equilibrium with NO2. Yet in still further aspects, the liquid N2O4is in equilibrium with gaseous nitrogen dioxide (NO2) or a gaseous mixture of dinitrogen tetroxide N2O4 and nitrogen dioxide (NO2). The container allows N2O4to interact with an antioxidant material and to produce nitric oxide.Attorney Docket No. 11637-054WO1

[0119] In still further aspects, it is understood that N2O4 can be present not as a pure liquid form. For example, N2O4 can be present as incorporated in additional media. For example, and without limitations, N2O4 can be present as a gel or any other matrix. It is understood that in such aspects, the media and / or matrix are not reactive towards N2O4. In such aspects, the media or matrix serves as a host of N2O4 to improve, for example, and without limitations, the safety and accessibility of the device.

[0120] In certain aspects, the antioxidant can be disposed within a solid matrix. In some aspects, the solid matrix can be a porous matrix. Yet, in other aspects, the solid matrix can have any form that would allow a high surface area and penetration of the antioxidant within the solid matrix. In still further aspects, it is understood, and without being bound by any theory, that the high surface area of the solid matrix would allow for a more efficient interaction between the antioxidant and N2O4 and / or NO2 to produce nitric oxide. In still further aspects, the antioxidant can be present without the solid matrix. For example, and without limitations, the antioxidant can be presented as a fluid. In certain aspects, the fluid can be stationary. Yet, in other aspects, the fluid can be moved as needed to ensure a desired mixing between the antioxidant and the N2O4 and / or NO2 to produce nitric oxide.

[0121] Antioxidants can comprise any known in the art antioxidants. In some aspects, the antioxidant can comprise ascorbic acid; alpha-, beta-, gamma-, or delta tocopherol; alpha-, beta-, gamma-, or delta-tocotrienol; polyphenols; betacarotene; or a combination thereof. In still further aspects, the media comprising antioxidants can also comprise at least some amount of moisture.

[0122] In aspects where the solid matrix is present, such a solid matrix can comprise silica gel or other suitable high-surface area wettable material that is wetted, coated, or impregnated with the antioxidant. Nitrogen dioxide can react with an aqueous solution of the antioxidant to produce nitric oxide, following the following reactions:a. 6NO2(gas) + 3H2O (liq.) ^ 3HNO3 (liq.) + 3HNO2(liq.) Eq. 1a b. 3HNO2(liq.) HNO3 (liq.) + 2NO (gas) + H2O (liq.) Eq. 1bAttorney Docket No. 11637-054WO1

[0123] Yet, in other aspects, the NO can be formed according to Eq. 2a-2b: CeHsOe + NO2 => CeHeOe + NO + H2O Eq. 2a3NO2+ H2O => 2HNO3+ NO Eq. 2b

[0124] Ascorbic acid-wetted solid matrices (or other suitable antioxidantcontaining materials) can be functionally similar to the media described in U.S. Patent Nos. 8,607,785, 8,944,049, 9,604,028, 10,926,054, 11,744,978, the contents of which are incorporated herein in their whole entirety.

[0125] Any of the disclosed above antioxidants can be present in an aqueous solution in a concentration of 0 and 50 wt%, including exemplary values of 1 wt%, 5 wt%, 10 wt%, 15 wt%, 20 wt%, 25 wt%, 30 wt%, 35 wt%, 40 wt%, and 45 wt%. It is understood that antioxidants can be present in any amount that falls between any two disclosed above values, or they can be present in any range that can be formed by any two values that fall within the broadest range. For example, the antioxidant can be present in an amount of 1 wt% to 40 wt%, 1 wt% to 32 wt%, or 5 wt% to 32 wt%, or 15 wt% to 45 wt%, 1 wt% to 15 wt%, or 10 wt % to 15 wt%, and so on. It may be desirable for the antioxidant concentration to be at or below the room temperature solubility limit because, at higher concentrations, the antioxidant may precipitate out, which could produce inconsistent nitric oxide conversion dynamics. It should be understood, however, that it may be possible to further increase the concentration of antioxidants by heating an antioxidant solution before wetting the solid matrix.

[0126] In still further aspects, the antioxidant is dispersed within a media comprising a support material having a specific surface area of 350 to 5000 m2 / g, including exemplary values of 400 m2 / g, 500 m2 / g, 600 m2 / g, 700 m2 / g, 800 m2 / g, 900 m2 / g, 1000 m2 / g, 1250 m2 / g, 1500 m2 / g, 1750 m2 / g, 2000 m2 / g, 2250 m2 / g, 2500 m2 / g, 2750 m2 / g, 3000 m2 / g, 3250 m2 / g, 3500 m2 / g, 3750 m2 / g, 4000 m2 / g, 4250 m2 / g, 4500 m2 / g, 4750 m2 / g, and 4990 m2 / g. It is understood that the specific surface area can be in any range formed between any two foregoing values. For example, and without limitations, the specific surface area can be 350 to 4500 m2 / g, 400 to 5000 m2 / g, 400 to 4000 m2 / g, 500 to 5000 m2 / g, or 500 to 4000 m2 / g, or 500 to 3000 m2 / g or 500 to 2000 m2 / g, and so on.Attorney Docket No. 11637-054WO1

[0127] Some exemplary media is described in U.S. Patent Application No.63 / 573,175, the content of which is incorporated herein is all entirety.

[0128] It is further understood that the single-use container can be provided in different dosing versions. In such aspects, the different dosing versions of singleuse containers can be color-coded and RFID identifiable to distinguish the dosing range and environments of use. Additional possible versions of the single-use container can include high-flow / high-dose and low-flow / low-dose containers, containers for cardiac catheterization labs, standard-dose containers, micro-dose containers, containers for use in neonatal, pediatric, or adult treatment, or containers to provide the treatment during transport of the patient (for example, in the ambulance, medical helicopter, or any other vehicle or aircraft).

[0129] In still further aspects, the first apparatus 200 and the second apparatus 300 can be attached to each other by different methods known in the art.

[0130] For example, and without limitations, the first apparatus can comprise a docking connection 208 configured to electrically connect the first apparatus with the second apparatus (FIG. 3). In such exemplary and unlimiting aspects, the docking connection 208 can be substantially concealed when the first apparatus is not connected to the second apparatus to prevent damage. For example, it can be concealed with a cover 210. In still further aspects, any connection ports that can be sealed to prevent moisture or dust damage, or any other damage that can affect the operation of the system. The removable cover 210 can contain a seal around its perimeter to prevent ingress of dust, dirt, moisture, or liquid. When the cover is removed and the second apparatus is connected, a seal is also made around its perimeter in the same manner.

[0131] In still further aspects, the electrical connection between the first apparatus and the second apparatus is wired, wireless, or a combination thereof.

[0132] It is further understood that the first apparatus and / or second apparatus are independently configured to operate in horizontal and / or vertical orientation, for example, as shown in FIGs. 2 and 5.

[0133] Also disclosed herein a system comprising: a first apparatus configured to form an amount of nitric oxide, a second apparatus that is configured to beAttorney Docket No. 11637-054WO1releasably attached to the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; wherein the second apparatus is configured to deliver a breathing gas to a patient; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0134] The first and the second apparatuses are similar to those disclosed above. Similarly, the control unit used in this system is similar to one disclosed above.

[0135] This exemplary system does not have to be connected to the CPB setup. Instead, it can be flu idical ly connected with the patient to deliver the breathing gas. This connection can be substantially direct or through a ventilator.

[0136] This system, instead of delivering a sweep gas to the patient, is configured to deliver the breathing gas. In such aspects, the breathing gas comprises an oxygen-enriched air. The nitric oxide can be delivered to the breathing gas in similar ways as disclosed above.

[0137] Also, in certain aspects, similarly to the systems disclosed above, the first apparatus can operate as a standalone device when the second apparatus is not attached to the first apparatus and is configured to directly deliver the amount of nitric oxide to a patient.

[0138] The breathing gas, if needed, can also comprise carbon dioxide, helium, hydrogen, medications, anesthetic agents, etc. All these gases are delivered by use of a mixing means in the second apparatus as described above.METHODS

[0139] Also disclosed herein is a method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup. Also disclosed is a method of delivering a breathing gas to a patient.

[0140] Such methods can comprise providing any of the systems disclosed above and delivering the desired gases as needed.Attorney Docket No. 11637-054WO1

[0141] Also disclosed is a method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing any of the disclosed above first apparatuses configured to form an amount of nitric oxide, releasably attaching the first apparatus to any of the disclosed above second apparatuses such that a fluid and / or communication connectivity is formed between the first apparatus and the second apparatus; releasably attaching the second apparatus to the CPB setup; wherein the second apparatus is configured to deliver the sweep gas to the CPB setup; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both when the first apparatus and the second apparatus are communicatively connected.

[0142] Also disclosed herein is a method of delivering gases to a cardiopulmonary bypass (CPB) setup, comprising: detecting, by any of the disclosed above first apparatuses, a communication connectivity with any of the disclosed above releasably attachable second apparatus; forming, by the first apparatus, an amount of nitric oxide; forming, by the second apparatus, a predetermined amount of a mixed gas; adding a predetermined portion of the amount of nitric oxide to the mixed gas to form a sweep gas; and delivering the sweep gas to a cardiopulmonary bypass (CPB) setup.

[0143] In certain aspects, the CPB setup comprises an extracorporeal membrane oxygenation (ECMO) device.

[0144] In other aspects, instead of forming the sweep gas, the system can form a breathing gas that can be delivered to the patient directly or through the ventilator. The methods of delivery are similar, with the exception of connecting to a CPB device or an ECMO device.

[0145] The methods can further comprise operating the first apparatus in a first mode when the second apparatus does not have a communication connectivity with the first apparatus, and operating the first apparatus in a second mode when the second apparatus has a communication connectivity with the first apparatus.

[0146] In certain aspects, the methods comprise changing a display of a user interface of the first apparatus when the first apparatus is in the second mode.Attorney Docket No. 11637-054WO1

[0147] The methods can further comprise enabling parameters in the first apparatus when the first apparatus is in the second mode.

[0148] In still further aspects, the parameters are associated with the sweep gas and / or breathing gas as desired.

[0149] While various aspects have been described above, it should be understood that they have been presented by way of example only and not limitation. Furthermore, although various aspects have been described as having particular features and / or combinations of components, other aspects possibly have a combination of any features and / or components from any of the aspects, where appropriate, as well as additional features and / or components.

[0150] Where methods described above indicate certain events occurring in a certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process, when possible, as well as performed sequentially as described above. Although various aspects have been described as having particular features and / or combinations of components, other aspects possibly have a combination of any features and / or components from any of the aspects, where appropriate.EXEMPLARY ASPECTS

[0151] Example 1. A system comprising: (a) a first apparatus configured to form an amount of nitric oxide, (b) a second apparatus configured to be releasably attached to (i) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / or (ii) a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; and (c) a control unit wherein the control unit is configured to independently control operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0152] Example 2. The system of any one of the examples herein, particularly Example 1 , wherein the control unit is positioned within the first apparatus.Attorney Docket No. 11637-054WO1

[0153] Example 3. The system of any one of the examples herein, particularly any one of Examples 1 or 2, wherein the sweep gas comprises a predetermined portion of the amount of nitric oxide.

[0154] Example 4. The system of any one of the examples herein, particularly any one of Examples 1-3, wherein the sweep gas comprises an oxygen-enriched air.

[0155] Example 5. The system of any one of Examples 1-4, wherein the first apparatus operates as a standalone device when the second apparatus is not attached to the first apparatus, and is configured to directly deliver the amount of nitric oxide to a patient.

[0156] Example 6. The system of any one of the examples herein, particularly Example 5, wherein the amount of nitric oxide is delivered to the patient through a ventilation device.

[0157] Example 7. The system of any one of the examples herein, particularly any one of Examples 1-6, wherein the second apparatus comprises one or more gas inlets and a mixing means, wherein the one or more gas inlets are in fluid communication with the mixing means, wherein each of the one or more gas inlets is configured independently to deliver one or more gases to the mixing means.

[0158] Example 8. The system of any one of the examples herein, particularly Example 7, wherein the one or more gas inlets comprise an oxygen inlet, an air inlet, a carbon dioxide inlet, or a combination thereof.

[0159] Example 9. The system of any one of the examples herein, particularly any one of Examples 7-8, wherein the one or more gas inlets further comprise a hydrogen inlet, a helium inlet, ora combination thereof.

[0160] Example 10. The system of any one of the examples herein, particularly any one of Examples 7-9 wherein the one or more gas inlets are configured to deliver an amount of the one or more gases simultaneously to the mixing means to form a mixed gas.

[0161] Example 11. The system of any one of the examples herein, particularly any one of Examples 7-10, wherein the one or more gas inlets are configured toAttorney Docket No. 11637-054WO1deliver an amount of the one or more gases in a predetermined sequence to the mixing means to form a mixed gas.

[0162] Example 12. The system of any one of the examples herein, particularly any one of Examples 10 or 11 , wherein the amount and the delivery sequence of the one or more gases are at least partially controlled by the control unit.

[0163] Example 13. The system of any one of the examples herein, particularly any one of Examples 7-12, wherein the second apparatus comprises a gas outlet that is in fluid communication with the mixing means and is configured to deliver a mixed gas to the CPB setup.

[0164] Example 14. The system of any one of the examples herein, particularly Example 13, wherein the predetermined portion of the amount of nitric oxide is injected from a dosing port in the first apparatus into the mixed gas after it leaves the second apparatus, thereby forming the sweep gas that is delivered to the CPB setup.

[0165] Example 15. The system of any one of the examples herein, particularly Example 13, wherein the predetermined portion of the amount of nitric oxide is delivered into the mixing means in a predetermined delivery sequence, and wherein the mixed gas is the sweep gas that is delivered to the CPB setup.

[0166] Example 16. The system of any one of the examples herein, particularly any one of Examples 7-15, wherein the second apparatus comprises an inlet to deliver an amount of water or water vapor to a mixed gas.

[0167] Example 17. The system of any one of the examples herein, particularly any one of Examples 7-16, wherein the second apparatus further comprises a humidification mechanism configured to add water vapor to a mixed gas.

[0168] Example 18. The system of any one of the examples herein, particularly any one of Examples 1-17, wherein the first apparatus and / or second apparatus are in fluid communication with a humidifying apparatus configured to control a humidity of the sweep gas.

[0169] Example 19. The system of any one of the examples herein, particularly Example 18, wherein the humidifying apparatus is positioned within the first apparatus and / or the second apparatus.Attorney Docket No. 11637-054WO1

[0170] Example 20. The system of any one of the examples herein, particularly any one of Examples 1-19, wherein the second apparatus comprises one or more fluid controlling components, wherein the one or more fluid controlling components comprise valves, flow controllers, sensors, or any combination thereof.

[0171] Example 21. The system of any one of the examples herein, particularly Example 20, wherein the one or more fluid controlling components are controlled by the control unit.

[0172] Example 22. The system of any one of the examples herein, particularly any one of Examples 20 or 21 , wherein the one or more fluid controlling components are configured to form a mixed gas having a predetermined composition.

[0173] Example 23. The system of any one of the examples herein, particularly any one of Examples 1-22, wherein the CPB setup comprises an extracorporeal membrane oxygenation (ECMO) device.

[0174] Example 24. The system of any one of the examples herein, particularly any one of Examples 1-23, wherein the first apparatus comprises a docking connection configured to electrically connect the first apparatus with the second apparatus.

[0175] Example 25. The system of any one of the examples herein, particularly Example 24, wherein the docking connection is substantially concealed when the first apparatus is not connected to the second apparatus, to prevent damage.

[0176] Example 26. The system of any one of the examples herein, particularly any one of Examples 1-25, wherein communication connectivity between the first apparatus and the second apparatus is wired, wireless, or a combination thereof.

[0177] Example 27. The system of any one of the examples herein, particularly any one of Examples 1-26, wherein the first apparatus and / or second apparatus are independently configured to operate in horizontal and / or vertical orientation.

[0178] Example 28. The system of any one of the examples herein, particularly any one of Examples 1-27, wherein when the second apparatus is attached to the first apparatus, concentrations of gas components present in the sweep gas, a flow rate, or a combination thereof, is controlled by the control unit.Attorney Docket No. 11637-054WO1

[0179] Example 29. The system of any one of the examples herein, particularly any one of Examples 1-28, wherein the control unit comprises a graphical user interface (GUI) configured to display user information reflecting the operation of the system.

[0180] Example 30. The system of any one of the examples herein, particularly Example 29, wherein the displayed user information is different when the first apparatus and the second apparatus are attached and in electrical communication from the displayed user information when the first apparatus and the second apparatus are not attached.

[0181] Example 31. The system of any one of the examples herein, particularly any one of Examples 1-30, wherein the second apparatus is not independently operational when it is not attached to the first apparatus.

[0182] Example 32. The system of any one of the examples herein, particularly any one of Examples 1-31 , wherein when the first apparatus determines that the second apparatus is communicatively connected, the first apparatus activates a sweep gas mode to enable the second apparatus to deliver the sweep gas to the CPB setup.

[0183] Example 33. The system of any one of the examples herein, particularly any one of Examples 1-32, wherein the first apparatus comprises at least one air inlet; a first receptacle configured to host a first source of nitric oxide; and a second receptacle configured to host a second source of nitric oxide.

[0184] Example 34. The system of any one of the examples herein, particularly any of Examples 1-33, wherein the first apparatus samples the sweep gas to measure concentrations of gas components present in the sweep gas.

[0185] Example 35. The system of any one of the examples herein, particularly Example 34, wherein the control unit analyses the concentrations of the gas components present in the sweep gas and, if needed, provides a directive to the first apparatus and / or second apparatus: a) to adjust gas concentration in the mixing means of the second apparatus, and / or b) to change the predetermined amount of nitric oxide.Attorney Docket No. 11637-054WO1

[0186] Example 36. The system of any one of the examples herein, particularly any one of Examples 33-35, wherein the control unit independently determines whether the first apparatus is attached or not attached to the second apparatus and is configured to communicate with the first receptacle and the second receptacle and to selectively couple the at least one air inlet to the first receptacle and the second receptacle to deliver the amount of nitric oxide from the first source and the second source.

[0187] Example 37. The system of any one of the examples herein, particularly any one of Examples 33-36, wherein the first apparatus further comprises a first outlet coupled to the first receptacle and a second outlet coupled to the second receptacle.

[0188] Example 38. The system of any one of the examples herein, particularly Example 37, wherein when the first apparatus is not attached to the second apparatus, the first and the second outlets are configured to deliver the amount of nitric oxide to a subject.

[0189] Example 39. The system of any one of the examples herein, particularly Example 38, wherein when the first apparatus is attached to the second apparatus, the first and the second outlets are configured to deliver a predetermined portion of the amount of nitric oxide to the sweep gas.

[0190] Example 40. The system of any one of the previous claims, wherein the control unit is configured to determine the amount of nitric oxide and / or the predetermined portion of the amount of nitric oxide based on one or more of patient measurements comprising blood oxygen saturation, blood carbon dioxide saturation, pulse rate, temperature, respiration rate, blood pressure, pH, or any combination thereof.

[0191] Example 41. A method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing a system comprising: (a) a first apparatus configured to form an amount of nitric oxide, (b) a second apparatus that is configured to be releasably attached to (i) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / or (ii) aAttorney Docket No. 11637-054WO1cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; and c) a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0192] Example 42. A method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing a first apparatus configured to form an amount of nitric oxide, releasably attaching the first apparatus to a second apparatus such that a fluid and / or communication connectivity is formed between the first apparatus and the second apparatus; releasably attaching the second apparatus to the CPB setup; wherein the second apparatus is configured to deliver the sweep gas to the CPB setup; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both when the first apparatus and the second apparatus are communicatively connected.

[0193] Example 43. The method of any one of the examples herein, particularly Example 42, wherein the control unit is positioned in the first apparatus.

[0194] Example 44. The method of any one of the examples herein, particularly Example 43, wherein the second apparatus is not independently operational when it is not attached to the first apparatus.

[0195] Example 45. A method of delivering gases to a cardiopulmonary bypass (CPB) setup, comprising: detecting, by a first apparatus, a communication connectivity with a releasably attachable second apparatus; forming, by the first apparatus, an amount of nitric oxide; forming, by the second apparatus, a predetermined amount of a mixed gas; adding a predetermined portion of the amount of nitric oxide to the mixed gas to form a sweep gas; and delivering the sweep gas to a cardiopulmonary bypass (CPB) setup.

[0196] Example 46. The method of any one of the examples herein, particularly Example 45, wherein the CPB setup comprises an extracorporeal membrane oxygenation (ECMO) device.Attorney Docket No. 11637-054WO1

[0197] Example 47. The method of any one of the examples herein, particularly any one of Examples 45 or 46, further comprising: operating the first apparatus in a first mode when the second apparatus does not have a communication connectivity with the first apparatus; and operating the first apparatus in a second mode when the second apparatus has a communication connectivity with the first apparatus.

[0198] Example 48. The method of any one of the examples herein, particularly Example 47, further comprising changing a display of a user interface of the first apparatus when the first apparatus is in the second mode.

[0199] Example 49. The method of any one of the examples herein, particularly any of Examples 47 and 48, further comprising enabling parameters in the first apparatus when the first apparatus is in the second mode.

[0200] Example 50. The method of any one of the examples herein, particularly Example 49, wherein the parameters are associated with the sweep gas.

[0201] Example 51. A system comprising: a first apparatus configured to form an amount of nitric oxide, a second apparatus that is configured to be releasably attached to the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; wherein the second apparatus is configured to deliver a breathing gas to a patient; and a control unit wherein the control unit is configured to independently control the operation of the first apparatus, the second apparatus, and the combination of both, when the first apparatus and the second apparatus are communicatively connected.

[0202] Example 52. The system of any one of the examples herein, particularly Example 51 , wherein the control unit is positioned within the first apparatus.

[0203] Example 53. The system of any one of the examples herein, particularly any one of Examples 51 or 52, wherein the breathing gas comprises a predetermined portion of the amount of nitric oxide.

[0204] Example 54. The system of any one of the examples herein, particularly any one of Examples 51-53, wherein the breathing gas comprises an oxygen-enriched air.Attorney Docket No. 11637-054WO1

[0205] Example 55. The system of any one of the examples herein, particularly any one of Examples 51-54, wherein the first apparatus operates as a standalone device when the second apparatus is not attached to the first apparatus and is configured to directly deliver the amount of nitric oxide to a patient.

[0206] Example 56. The system of any one of the examples herein, particularly Example 55, wherein the amount of nitric oxide is delivered to the patient through a ventilation device.

[0207] Example 57. The system of any one of the examples herein, particularly any one of Examples 51-56, wherein the second apparatus comprises one or more gas inlets and a mixing means, wherein the one or more gas inlets are in fluid communication with the mixing means, wherein each of the one or more gas inlets is configured independently to deliver one or more gases to the mixing means.

[0208] Example 58. The system of any one of the examples herein, particularly Example 57, wherein the one or more gas inlets comprise an oxygen inlet, an air inlet, a carbon dioxide inlet, or a combination thereof.

[0209] Example 59. The system of any one of the examples herein, particularly any one of Examples 57-58, wherein the one or more gas inlets further comprise a hydrogen inlet, a helium inlet, ora combination thereof.

[0210] Example 60. The system of any one of the examples herein, particularly any one of Examples 57-59 wherein the one or more gas inlets are configured to deliver an amount of the one or more gases simultaneously to the mixing means to form a mixed gas.

[0211] Example 61. The system of any one of the examples herein, particularly any one of Examples 57-60, wherein the one or more gas inlets are configured to deliver an amount of the one or more gases in a predetermined sequence to the mixing means to form a mixed gas.

[0212] Example 62. The system of any one of the examples herein, particularly any one of Examples 60 or 61 , wherein the amount and the delivery sequence of the one or more gases are at least partially controlled by the control unit.

[0213] Example 63. The system of any one of the examples herein, particularly any one of Examples 57-62, wherein the second apparatus comprises a gas outletAttorney Docket No. 11637-054WO1that is in fluid communication with the mixing means and is configured to deliver a mixed gas to the patient.

[0214] Example 64. The system of any one of the examples herein, particularly Example 63, wherein the predetermined portion of the amount of nitric oxide is injected from a dosing port in the first apparatus into the mixed gas after it leaves the second apparatus, thereby forming the breathing gas.

[0215] Example 65. The system of any one of the examples herein, particularly Example 63, wherein the predetermined portion of the amount of nitric oxide is delivered into the mixing means in a predetermined delivery sequence, and wherein the mixed gas is the breathing gas.

[0216] Example 66. The system of any one of the examples herein, particularly any one of Examples 57-65, wherein the second apparatus comprises an inlet to deliver an amount of water or water vapor to a mixed gas.

[0217] Example 67. The system of any one of the examples herein, particularly any one of Examples 57-66, wherein the second apparatus further comprises a humidification mechanism configured to add water vapor to a mixed gas.

[0218] Example 68. The system of any one of Examples 51-67, wherein the first apparatus and / or second apparatus are in fluid communication with a humidifying apparatus configured to control a humidity of the breathing gas.

[0219] Example 69. The system of any one of the examples herein, particularly Example 68, wherein the humidifying apparatus is positioned within the first apparatus and / or second apparatus.

[0220] Example 70. The system of any one of the examples herein, particularly any one of Examples 51-69, wherein the second apparatus comprises one or more fluid controlling components, wherein the one or more fluid controlling components comprise valves, flow controllers, sensors, or any combination thereof.

[0221] Example 71. The system of any one of the examples herein, particularly Example 70, wherein the one or more fluid controlling components are controlled by the control unit.Attorney Docket No. 11637-054WO1

[0222] Example 72. The system of any one of the examples herein, particularly any one of Examples 70 or 71 , wherein the one or more fluid controlling components are configured to form a mixed gas having a predetermined composition.

[0223] Example 73. The system of any one of the examples herein, particularly any one of Examples 51-72, wherein the first apparatus comprises a docking connection configured to electrically connect the first apparatus with the second apparatus.

[0224] Example 74. The system of any one of the examples herein, particularly Example 73, wherein the docking connection is substantially concealed when the first apparatus is not connected to the second apparatus to prevent damage.

[0225] Example 75. The system of any one of the examples herein, particularly any one of Examples 51-74, wherein the electrical and / or communication connection between the first apparatus and the second apparatus is wired, wireless, or a combination thereof.

[0226] Example 76. The system of any one of the examples herein, particularly any one of Examples 51-75, wherein the first apparatus and / or second apparatus are independently configured to operate in horizontal and / or vertical orientation.

[0227] Example 77. The system of any one of the examples herein, particularly any one of Examples 51-76, wherein when the second apparatus is attached to the first apparatus, concentrations of gas components present in the breathing gas and / or nitric oxide-containing breathing gas, a flow rate, or a combination thereof is controlled by the control unit.

[0228] Example 78. The system of any one of the examples herein, particularly any one of Examples 51-77, wherein the control unit comprises a graphical user interface (GUI) configured to display user information reflecting the operation of the system.

[0229] Example 79. The system of any one of the examples herein, particularly Example 78, wherein the displayed user information is different when the first apparatus and the second apparatus are attached and in electrical communicationAttorney Docket No. 11637-054WO1from the displayed user information when the first apparatus and the second apparatus are not attached.

[0230] Example 80. The system of any one of the examples herein, particularly any one of Examples 51-79, wherein the second apparatus is not independently operational when it is not attached to the first apparatus.

[0231] Example 81. The system of any one of the examples herein, particularly any one of Examples 51-80, wherein when the first apparatus determines that the second apparatus is communicatively connected, the first apparatus activates a breathing gas mode to enable the second apparatus to deliver the breathing gas to the patient.

[0232] Example 82. The system of any one of the examples herein, particularly any one of Examples 51-81 , wherein the first apparatus comprises at least one air inlet; a first receptacle configured to host a first source of nitric oxide; and a second receptacle configured to host a second source of nitric oxide.

[0233] Example 83. The system of any one of the examples herein, particularly any of Examples 51-82, wherein the first apparatus samples the breathing gas to measure concentrations of gas components present in the breathing gas.

[0234] Example 84. The system of any one of the examples herein, particularly Example 83, wherein the control unit analyses the concentrations of the gas components present in the breathing gas and, if needed, provides a directive to the first apparatus and / or second apparatus: a) to adjust gas concentration in the mixing means of the second apparatus, and / or b) to change the predetermined amount of nitric oxide.

[0235] Example 85. The system of any one of the examples herein, particularly any one of Examples 82-84, wherein the control unit independently determines whether the first apparatus is attached or not attached to the second apparatus and is configured to communicate with the first receptacle and the second receptacle and to selectively couple the at least one air inlet to the first receptacle and the second receptacle to deliver the amount of nitric oxide from the first source and the second source.Attorney Docket No. 11637-054WO1

[0236] Example 86. The system of any one of Examples 82-85, wherein the first apparatus further comprises a first outlet coupled to the first receptacle and a second outlet coupled to the second receptacle.

[0237] Example 87. The system of any one of the examples herein, particularly Example 86, wherein when the first apparatus is not attached to the second apparatus, the first and the second outlets are configured to deliver the amount of nitric oxide to a subject.

[0238] Example 88. The system of any one of the examples herein, particularly Example 87, wherein when the first apparatus is attached to the second apparatus, the first and the second outlets are configured to deliver a predetermined portion of the amount of nitric oxide to the breathing gas.

[0239] Example 89. The system of any one of the previous claims, wherein the control unit is configured to determine the amount of nitric oxide and / or the predetermined portion of the amount of nitric oxide based on one or more of patient measurements comprising blood oxygen saturation, blood carbon dioxide saturation, pulse rate, temperature, respiration rate, blood pressure, pH, or any combination thereof.

Claims

Attorney Docket No. 11637-054WO1CLAIMSWhat is claimed is:

1. A system comprising:a) a first apparatus configured to form an amount of nitric oxide, b) a second apparatus configured to be releasably attached toi) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / orii) a cardiopulmonary bypass (CPB) setup, such thata fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; andc) a control unit wherein the control unit is configured to independently control operation of the first apparatus, the second apparatus, and a combination of both, when the first apparatus and the second apparatus are communicatively connected.

2. The system of claim 1 , wherein the control unit is positioned within the first apparatus.

3. The system of claim 1 or 2, wherein the sweep gas comprises a predetermined portion of the amount of nitric oxide, and / or wherein the sweep gas comprises an oxygen-enriched air.

4. The system of any one of claims 1 -3, wherein the first apparatus operates as a standalone device when the second apparatus is not attached to the first apparatus, and / or herein the second apparatus is not independently operational when it is not attached to the first apparatus, and wherein the first apparatus is not attached to the second apparatus it is configured to directly deliver the amount of nitric oxide to a patient.

5. The system of any one of claims 1 -4, wherein the second apparatus comprises one or more gas inlets and a mixing means, wherein the one or moreAttorney Docket No. 11637-054WO1gas inlets are in fluid communication with the mixing means, wherein each of the one or more gas inlets is configured independently to deliver one or more gases to the mixing means, and wherein the one or more gas inlets comprise an oxygen inlet, an air inlet, a carbon dioxide inlet, or a combination thereof.

6. The system of claim 5, wherein the one or more gas inlets further comprise a hydrogen inlet, a helium inlet, or a combination thereof.

7. The system of any one of claims 5-6, wherein the one or more gas inlets are configured to deliver an amount of the one or more gases simultaneously to the mixing means to form a mixed gas and / or wherein the one or more gas inlets are configured to deliver an amount of the one or more gases in a predetermined sequence to the mixing means to form a mixed gas.

8. The system of any one of claim 7, wherein the amount and a delivery sequence of the one or more gases are at least partially controlled by the control unit.

9. The system of any one of claims 5-8, wherein the second apparatus comprises a gas outlet that is in fluid communication with the mixing means and is configured to deliver a mixed gas to the CPB setup.

10. The system of claim 9, wherein a predetermined portion of the amount of nitric oxide is injected from a dosing port in the first apparatus into the mixed gas after it leaves the second apparatus, thereby forming the sweep gas that is delivered to the CPB setup; or wherein a predetermined portion of the amount of nitric oxide is delivered into the mixing means in a predetermined delivery sequence, and wherein the mixed gas is the sweep gas that is delivered to the CPB setup.

11. The system of any one of claims 5-10, wherein the second apparatus comprises an inlet to deliver an amount of water or water vapor to a mixed gas, and / or wherein the second apparatus further comprises a humidification mechanism configured to add water vapor to a mixed gas, and / or wherein the first apparatus and / or second apparatus are in fluid communication with a humidifying apparatus configured to control a humidity of the sweep gas.Attorney Docket No. 11637-054WO112. The system of any one of claims 1-11, wherein the second apparatus comprises one or more fluid controlling components, wherein the one or more fluid controlling components comprise valves, flow controllers, sensors, or any combination thereof, and wherein the one or more fluid controlling components are controlled by the control unit.

13. The system of any one of claims 1-12, wherein the CPB setup comprises an extracorporeal membrane oxygenation (ECMO) device.

14. The system of any one of claims 1 -13,wherein the first apparatus comprises a docking connection configured to electrically connect the first apparatus with the second apparatus, and wherein the docking connection is substantially concealed when the first apparatus is not connected to the second apparatus to prevent damage.

15. The system of any one of claims 1 -14, wherein the communication connectivity between the first apparatus and the second apparatus is wired, wireless, or a combination thereof.

16. The system of any one of claims 1 -15, wherein the first apparatus and / or second apparatus are independently configured to operate in horizontal and / or vertical orientation.

17. The system of any one of claims 1 -16, wherein when the second apparatus is attached to the first apparatus, concentrations of gas components present in the sweep gas, a flow rate, or a combination thereof, is controlled by the control unit.

18. The system of any one of claims 1 -17, wherein the control unit comprises a graphical user interface (GUI) configured to display user information reflecting the operation of the system, and wherein the displayed user information is different when the first apparatus and the second apparatus are attached and in electrical communication from the displayed user information when the first apparatus and the second apparatus are not attached.

19. The system of any one of claims 1 -18, wherein when the first apparatus determines that the second apparatus is communicatively connected, the firstAttorney Docket No. 11637-054WO1apparatus activates a sweep gas mode to enable the second apparatus to deliver the sweep gas to the CPB setup.

20. The system of any one of claims 1 -19, wherein the first apparatus comprisesat least one air inlet;a first receptacle configured to host a first source of nitric oxide; and a second receptacle configured to host a second source of nitric oxide, and wherein the first apparatus samples the sweep gas to measure concentrations of gas components present in the sweep gas.

21. The system of claim 20, wherein the control unit analyses the concentrations of the gas components present in the sweep gas and, if needed, provides a directive to the first apparatus and / or second apparatus:a) to adjust the gas concentration in mixing means of the second apparatus, and / orb) to change a predetermined amount of nitric oxide.

22. The system of any one of claims 20-21 , wherein the control unit independently determines whether the first apparatus is attached or not attached to the second apparatus and is configured to communicate with the first receptacle and the second receptacle and to selectively couple the at least one air inlet to the first receptacle and the second receptacle to deliver the amount of nitric oxide from the first source and the second source.

23. The system of any one of claims 20-22, wherein the first apparatus further comprises a first outlet coupled to the first receptacle and a second outlet coupled to the second receptacle, wherein when the first apparatus is not attached to the second apparatus, the first and the second outlets are configured to deliver the amount of nitric oxide to a subject and wherein when the first apparatus is attached to the second apparatus, the first and the second outlets are configured to deliver a predetermined portion of the amount of nitric oxide to the sweep gas.Attorney Docket No. 11637-054WO124. A method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providing a system comprising:a) a first apparatus configured to form an amount of nitric oxide, b) a second apparatus that is configured to be releasably attached to:i) the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus; and / orii) a cardiopulmonary bypass (CPB) setup, such that a fluid communication is formed between the second apparatus and the CPB setup, wherein the second apparatus is configured to deliver a sweep gas to the CPB setup; andc) a control unit wherein the control unit is configured to independently control operation of the first apparatus, the second apparatus, and a combination of both, when the first apparatus and the second apparatus are communicatively connected.

25. A method for forming and delivering a sweep gas to a cardiopulmonary bypass (CPB) setup, wherein the method comprises providinga first apparatus configured to form an amount of nitric oxide, releasably attaching the first apparatus to a second apparatus such that a fluid and / or communication connectivity is formed between the first apparatus and the second apparatus;releasably attaching the second apparatus to the CPB setup;wherein the second apparatus is configured to deliver the sweep gas to the CPB setup; anda control unit wherein the control unit is configured to independently control operation of the first apparatus, the second apparatus, and a combination of both when the first apparatus and the second apparatus are communicatively connected.Attorney Docket No. 11637-054WO126. A method of delivering gases to a cardiopulmonary bypass (CPB) setup, comprising:detecting, by a first apparatus, a communication connectivity with a releasably attachable second apparatus;forming, by the first apparatus, an amount of nitric oxide;forming, by the second apparatus, a predetermined amount of a mixed gas; adding a predetermined portion of the amount of nitric oxide to the mixed gas to form a sweep gas; anddelivering the sweep gas to a cardiopulmonary bypass (CPB) setup.

27. A system comprising:a first apparatus configured to form an amount of nitric oxide,a second apparatus that is configured to be releasably attached to the first apparatus, such that a fluid and / or a communication connectivity is formed between the second apparatus and the first apparatus;wherein the second apparatus is configured to deliver a breathing gas to a patient; anda control unit wherein the control unit is configured to independently control operation of the first apparatus, the second apparatus, and a combination of both, when the first apparatus and the second apparatus are communicatively connected.